Stocks
Bioverativ Inc.BIVV
YHDHealthcareBiotechnology
A biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders, with key products including extended half-life clotting factor treatments for hemophilia A and B. The business was spun out of Biogen in 2017, drawing investor attention for its concentrated rare-disease ...
Congressional Interest in Bioverativ Inc. (BIVV)
3 members of Congress have disclosed 9 trades in Bioverativ Inc. (BIVV), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 5 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
9
Unique Politicians
3
Buys
1
Sells
5
Who in Congress Is Trading BIVV?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-01-22 | Thomas MacArthur | sell | $15K – $50K |
| 2018-01-22 | Thomas MacArthur | sell | $1K – $15K |